Assessment of the antinociceptive and ulcerogenic activity of the tapentadol–diclofenac combination in rodents.
- Published in:
- Drug Development Research, 2018, v. 79, n. 1, p. 38, doi. 10.1002/ddr.21420
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2018 AND VI 79 AND IP 1
Results: 7
1
2
Pharmacological interaction of α‐bisabolol and diclofenac on nociception, inflammation, and gastric integrity in rats.
- Published in:
- Drug Development Research, 2018, v. 79, n. 1, p. 29, doi. 10.1002/ddr.21418
- By:
- Publication type:
- Article
3
Anti‐inflammatory and analgesic activities of cupressuflavone from <italic>Cupressus macrocarpa</italic>: Impact on pro‐inflammatory mediators.
- Published in:
- Drug Development Research, 2018, v. 79, n. 1, p. 22, doi. 10.1002/ddr.21417
- By:
- Publication type:
- Article
4
Free fatty acid receptor 1 agonist, MR1704, lowers blood glucose levels in rats unresponsive to the sulfonylurea, glibenclamide.
- Published in:
- Drug Development Research, 2018, v. 79, n. 1, p. 16, doi. 10.1002/ddr.21416
- By:
- Publication type:
- Article
5
Gastroprotective effect of calealactone B: Lack of involvement of prostaglandins, nitric oxide and sulfhydryls.
- Published in:
- Drug Development Research, 2018, v. 79, n. 1, p. 11, doi. 10.1002/ddr.21415
- By:
- Publication type:
- Article
6
Angelicin potentiates TRAIL‐induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down‐regulation of c‐FLIP expression.
- Published in:
- Drug Development Research, 2018, v. 79, n. 1, p. 3, doi. 10.1002/ddr.21414
- By:
- Publication type:
- Article
7
Issue Information – TOC.
- Published in:
- Drug Development Research, 2018, v. 79, n. 1, p. 1, doi. 10.1002/ddr.21351
- Publication type:
- Article